Serum prohepcidin and other iron metabolism parameters in elderly patients with anemia of chronic disease and with iron defciency anemia

Polskie Archiwum Medycyny Wewnetrznej

Volumn 123, Issue 3, 2013, Pages 105-111

  Przybyszewska, Justyna ^a   Zekanowska, Ewa ^a   Kȩdziora Kornatowska, Kornelia ^a   Boinska, Joanna ^a   Cichon, Roman ^a   Porzych, Katarzyna ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Anemia of chronic disease; Iron deficiency anemia; Prohepcidin

Indexed keywords

C REACTIVE PROTEIN; ERYTHROPOIETIN; FERRITIN; INTERLEUKIN 6; IRON; PROHEPCIDIN; TRANSFERRIN;

AGED; ANEMIA; ANEMIA OF CHRONIC DISEASE; ARTICLE; BLOOD CELL COUNT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FERRITIN BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; IRON BINDING CAPACITY; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON METABOLISM; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; STANDARD;

EID: 84877300259     PISSN: 00323772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Woodman R, Ferrucci L, Guralnik J. Anemia in older adults. Curr Opin Hematol. 2005; 12: 123-128.
2. Vanasse GJ, Berliner N. Anemia in elderly patients: an emerging problem for the 21st century. Hematology Am Soc Hematol Educ Program. 2010; 271-275.
3. Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004; 104: 2263-2268.
4. Guralnik JM, Ershler WB, Schrier SL, et al. Anemia in the Elderly: A Public Health Crisis in Hematology. Hematology. 2005; 1: 528-532.
5. Fleming RE, Sly WS. Hepcidin: a putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. PNAS. 2001; 98: 8160-8162.
6. De Domenico I, Zhang TY, Koening CL, et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest. 2010; 120: 2395-2405.
7. Ershler WB. Biological interactions of aging and anemia - a focus on cytokines. J Am Geriatr Soc. 2003; 51: 18-21.
8. Gabrilove J. Anemia and the elderly: clinical considerations. Best Pract Res Clin Haematol. 2005; 18: 417-422.
9. Ania BJ, Suman VJ, Fairbanks VF, et al. Incidence of anemia in older people: an epidemiologic study in a well defined population. J Am Geriatr Soc. 1997; 45: 825-831.
10. Balducci L, Hardy CL, Lyman GH. Hematopoietic growth factors in the older cancer patient. Curr Opin Hematol. 2001; 8: 170-187.
11. DiMaria-Ghalili RA, Amella E. Nutrition in Older Adults: Intervention and assessment can help curb the growing threat of malnutrition. AJN. 2005; 105: 40-50.
12. Young VR. Macronutrient needs in the elderly. Nutr Rev. 1992; 50: 454-462.
13. Baccin AC, Lazzaretti LL, Brandao VDM, et al. Oxidative stress in older patients with iron deficiency anaemia. J Nutr Health Aging. 2009; 13: 666-670.
14. Kaldara-Papatheodorou EE, Terrovitis JV, Nanas JN. Anemia in heart failure: should we supplement iron in patients with chronic heart failure? Pol Arch Med Wewn. 2010; 120: 354-360.
15. Stompór T, Olszewski A, Kierzkowska I. Can we prolong life of patients with advanced chronic kidney disease: what is the clinical evidence? Pol Arch Med Wewn. 2011;121: 88-93.
16. Guyatt GH, Patterson C, Ali M, et al. Diagnosis of iron-deficiency anemia in the elderly. Am J Med. 1990; 88: 205-209.
17. Krause A, Neitz S, Magert HJ, et al. LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett. 2000; 480: 147-150.
18. Park CH, Valore EV, Waring AJ, et al. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2001; 276: 7806-7810.
19. Knutson MD, Oukka M, Koss LM, et al. Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin. PNAS. 2005; 102: 1324-1328.
20. Nemeth E, Tuttle MS, Powelson J, et al. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization. Science. 2004; 306: 2090-2093.
21. Nicolas G, Chauvet C, Viatte L, et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J Clin Invest. 2002; 110: 1037-1044.
22. Domenico I, Ward DM, Kaplan J. Hepcidin regulation: ironing out the details. J Clin Invest. 2007; 117: 1755-1758.
23. Pietrangelo A, Dierssen U, Valli L, et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology. 2007; 132: 294-300.
24. Verga Falzacappa MV, Spasic MV, Kessler R, et al. STAT-3 mediates hepatic hepcidin expression and its inflammatory stimulation. Blood. 2007; 109: 353-358.
25. Balducci L. Epidemiology of Anemia in the Elderly: Information on Diagnostic Evaluation. J Am Geriatr Soc. 2003; 51: 2-9.
26. Casale G, Bonora C, Migliavacca A, et al. Serum ferritin and aging. Age Ageing. 1981; 10: 119-122.
27. Tull KI, Hirani V, Ali A, et al. Impact of different diagnostic thresholds and the anaemia-ferritin-transferrin receptor model on the prevalence of anaemia and impaired iron status in older people. Age Ageing. 2009; 38: 609-613.
28. Chua E, Clague JE, Sharma AK, et al. Serum transferrin receptor assay in iron deficiency anaemia and anaemia of chronic disease in the elderly. Q J Med. 1999; 92: 587-594.
29. Małyszko J, Koc-Żorawska E, Levin-Iaina N. New parameters in iron metabolism and functional iron deficiency in patients on maintenance hemodialysis. Pol Arch Med Wewn. 2012; 122: 537-542.
30. Cheng P P, Jiao X Y, Wang XH, et al. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med. 2011; 11: 33-42.
31. Nemeth E, Valore E V, Territo M, et al. Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2003; 101: 2461-2463.
32. Dallalio G, Fleury T, Means RT. Serum hepcidin in clinical specimens. Br J Haematol. 2003, 122: 996-1000.
33. Ferrucci L, Semba RD, Guralnik JM, et al. Proinflammatory state, hepcidin, and anemia in older persons. Blood. 2010; 115: 3810-3816.
34. Artz AS, Fergusson D, Drinka PJ, et al. Mechanisms of unexplained anemia in the nursing home. J Am Geriatrics Soc. 2004; 52: 423-427.
35. Brock JH, Mulero V. Cellular and molecular aspects of iron and immune function. Proc Nutr Soc. 2000; 59: 537-540.
36. Małyszko J, Levin-Iaina N, Myśliwiec M, et al. Iron metabolism in solid-organ transplantation: how far are we from solving the mystery? Pol Arch Med Wewn. 2012; 122: 504-511.
37. Peyssonnaux C, Zinkernagel AS, Datta V, et al. TLR4-dependent hepcidin expression by myeloid cells in response to bacterial pathogens. Blood. 2006; 107: 3727-3732.
38. Ganz T. The role of hepcidin in iron sequestration during infections and in the pathogenesis of anemia of chronic disease. Isr Med Assoc J. 2002; 4: 1043-1045.
39. Roe MA, Collings R, Dainty JR, et al. Plasma hepcidin concentrations significantly predict interindividual variation in iron absorption in healthy men. Am J Clin Nutr. 2009; 89: 1088-1091.
40. Ganz T, Olbina G, Girelli D, et al. Immunoassay for human serum hepcidin. Blood. 2008; 112: 4292-4297.
41. Tan TC, Crawford DH, Franklin ME, et al. The serum hepcidin: ferritin ratio is a potential biomarker for cirrhosis. Liver Int. 2012; 32: 1391-1399.
42. Lee P, Peng H, Gelbart T, et al. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci. 2005; 102: 1906-1910.
43. Nemeth E, Rivera S, Gabayan V, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004; 113: 1271-1276.
44. Pigeon C, Ilyin G, Courselaud B, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem. 2001; 276: 7811-7819.
45. Benedict C, Ghio AJ, Gehring H, et al. Transient hypoxia and downregulation of circulating prohepcidin concentrations in healthy young men. Haematologica. 2007; 92: 125-126.
46. Kemna EHJM, Pickkers P, Nemeth E, et al. Time-course analysis of hepcidin, serum iron, and plasma cytokine levels in humans injected with LPS. Blood. 2005; 106: 1864-1866.
47. Bekri S, Gual P, Anty R, et al. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology. 2006; 131: 691-693.
48. Chung B, Matak P, McKie AT, et al. Leptin Increases the Expression of the Iron Regulatory Hormone Hepcidin in HuH7 Human Hepatoma Cells. J Nutr. 2007; 137: 2366-2370.
49. Przybyszewska J, Żekanowska E, Kedziora-Kornatowska K, et al. Prohepcidin and iron metabolism parameters in the obese elderly patients with anemia. J Nutr Health Aging. 2011; 15: 259-264.
50. del Giudice EM, Santoro N, Amato A, et al. Hepcidin in obese children as a potential mediator of the association between obesity and iron deficiency. J Clin Endocrinol Metab. 2009; 94: 5102-5107.
51. Wians FH Jr, Urban JE, Keffer JH, et al. Discriminating between iron deficiency anemia and anemia of chronic disease using traditional indices of iron status vs transferrin receptor concentration. Am J Clin Pathol. 2001; 115: 112-118.